Clinical Trials Directory

Trials / Completed

CompletedNCT04051216

The SMART CART Study: Health Information Technology

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
148 (actual)
Sponsor
University of Michigan Rogel Cancer Center · Academic / Other
Sex
All
Age
3 Years
Healthy volunteers
Accepted

Summary

This study evaluates the feasibility of using two information technology tools in patients undergoing Chimeric Antigen Receptor T-cell (CART) therapy and other Cytokine Release Syndrome (CRS)-eliciting treatments such as CD123 BITE. The first is an Apple iPad® application called the BMT Roadmap, which shows information about the participant's health. The second is a wearable activity monitoring device. Health information technology tools such as Roadmap system and the activity monitoring device may enable caregivers and patients to become more active participants in their healthcare.

Detailed description

100 patients will be asked to participate in the wearable device portion of the study. 100 caregivers will be asked to participate in the Roadmap (iPad) portion of the study. Each caregiver will be provided with an iPad to use the BMT Roadmap system. Patients and/or caregivers are free to use this tool as much as they would like on their own time while in the hospital. The hospital care team will collect the iPad when the patient is discharged and ready to go home. Patients and caregivers will also be asked to take three surveys that will ask about their feelings and thoughts about the Roadmap application. The surveys will be completed when patients are admitted for their CART or other CRS-eliciting therapy, when they get discharged from the hospital and around 100 days after they receive their therapy. In addition to the use of the BMT Roadmap, this study will include around 7-10 interviews about participants' opinions on the two tools and their experience in the therapy process.

Conditions

Interventions

TypeNameDescription
BEHAVIORALEducation information systemParticipants will receive a mobile tablet as an educational intervention
OTHERActivity monitorParticipants will receive at least 1 of 4 activity monitoring devices
OTHERInterviewParticipants will be interviewed about their experience using the device(s)
OTHERSurvey AdministrationParticipants will receive surveys
OTHERLaboratory Biomarker AnalysisCorrelative studies

Timeline

Start date
2017-12-20
Primary completion
2023-08-25
Completion
2023-11-23
First posted
2019-08-09
Last updated
2024-03-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04051216. Inclusion in this directory is not an endorsement.